New update about CYP2D6 test

hlya

I posted in another forum but would like to share with you ILC girls here again:

http://community.breastcancer.org/forum/78/topic/747562?page=1#idx_15 

"A new study that found "slow metabolizers" of tamoxifen did not have a higher risk of recurrence has spurred further controversy over whether patients who don't fully metabolize the drug get the full benefit. The analysis, presented Friday at the San Antonio Breast Cancer Symposium, included more than 2,800 women with early-stage, estrogen receptor-positive breast cancer who received tamoxifen after surgery....

....."

http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1338